References
- Mohar N, Gruber F. Gonorrhoea to-day. Medicina 1979; 16: 81–88.
- Gruber F, Grubisic-Greblo H, Jonjic A, Markusic J. Treatment of gonococcal and chlamydial urethritis with azithromycin or doxycydine. Chron Derm 1995; 5: 213–218.
- Jones RN, Gavan TN, Thornsberry C et al. Stan-dardization of disk diffusion and dilution susceptibility tests for Neisseria gonorrhoeae: interpretative criteria and quality control guidelines for cefriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol 1989; 27: 2758–2766.
- Lassus A. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J Antimicrob Chemother 1990; 25 (Suppl E): 115-121.
- Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Single dose azithromycin treat-ment of gonorrhoea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21: 43-46.
- Waugh M. Open study of the safety and efficacy of a single dose of azithromycin for the treatment of uncomplicat-ed gonorrhoea in men and women. J Antimicrob Chemother 1993; 31 ( Suppl E): 193-198.
- Handsfield HH, Dalu ZA, Martin DA, Douglas JM, McCarty JM, Schlossberg D. Multicentric trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicat-ed gonorrhoea. Sex Transm Dis 1994; 21: 107–111.
- Gruber F, Stagic A, Lenkovic M, Brajac I. Azithromycin in the treatment of chlamydial urethritis in seamen. In Stary ed. Proc. Third Meeting of the European Society for Chlamydia Research,Vienna 1996: 453.
- Lewis DA, Ison CA, Livermore DM, Chen HY, Hooi AY, Wisdom AR. A one-year survey of Neisseria gonorrhoeae isolated from patients attending an east London genitourinary medicine clinic: susceptibility patterns and patients' charac-teristics. Genitourin Med 1995; 71: 13–17.
- Foulds G, Shepard RM, Johnson RB. The pharmacoki-netics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 (Suppl A): 73-82.
- Odugbemi T, Oyewole F, Isichei CS, Onwukeme KE, Adeyemi-Doro FA. Single oral dose of azithromycin for thera-py of susceptible sexually transmitted diseases: a multicenter open evaluation. West Afr J Med 1993; 12: 136–140.
- Tomazic J. Azithromycin and the immune system. Medicus 1994; 3: 167–172.